Author

Esperanza Perucha

King's College LondonORCID 0000-0002-7802-0875Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:proteomics· 1

Frequent Co-Authors

Daniel Larcombe-YoungiD· 1 shared Eva Bugallo-BlancoiD· 1 shared Jennifer RynneiD· 1 shared Olivier MartíneziD· 1 shared Onofrio ZaniniD· 1 shared Paniz Khooshemehri· 1 shared Robert Lee Page IIiD· 1 shared Rocío T. Martínez-NuñeziD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Daniel Larcombe-YoungORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

IGF2BP3 inhibits IL-13 and IL-4 effects in human airway epithelium and is dysregulated in type 2 disease

Paniz Khooshemehri, Onofrio Zanin, Jennifer Rynne, Esperanza Perucha, Rocío T. Martínez-Nuñez

This study shows IGF2BP3 inhibits IL-13 and IL-4 effects in airway epithelium and is upregulated in type 2 diseases, correlating with an IL-13-driven signature.

bioRxiv · Jul 19, 2025 · PreprintMolecular Biology

GLUT5 armouring enhances adoptive T cell therapy anti-tumour activity under glucose-limiting conditions

Robert Lee Page II, Olivier Martínez, Daniel Larcombe-Young, Eva Bugallo-Blanco, Sophie Papa, Esperanza Perucha

This paper shows that modifying T cells to use fructose via GLUT5 improves their anti-tumor activity in low-glucose environments.

Immunotherapy Advances · Dec 30, 2024Peer-reviewedCancer Biology